UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue.
--------------------------------------------------------------------------------
1. Name and Address of Reporting Person(s)
Essig, Stuart M.
--------------------------------------------------------------------------------
(Last) (First) (Middle)
--------------------------------------------------------------------------------
311 Enterprise Drive
--------------------------------------------------------------------------------
(Street)
Plainsboro, New Jersey 08536
--------------------------------------------------------------------------------
(City) (State) (Zip)
--------------------------------------------------------------------------------
2. Issuer Name and Ticker or Trading Symbol
Integra LifeSciences Holdings Corp. (IART)
--------------------------------------------------------------------------------
3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)
--------------------------------------------------------------------------------
4. Statement for Month/Day/Year
03/18/2003
--------------------------------------------------------------------------------
5. If Amendment, Date of Original (Month/Day/Year)
--------------------------------------------------------------------------------
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
[X] Director [ ] 10% Owner
[X] Officer (give title below) [ ] Other (specify below)
President and Chief Executive
Officer
--------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
[X] Form filed by One Reporting Person
[ ] Form filed by More than One Reporting Person
--------------------------------------------------------------------------------
Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
------------------------------------------------------------------------------------------------------------------------------------
1)Title of Security 2)Trans- 3.Trans- 4.Securities Acquired(A) 5)Amount of 6) 7)Nature of
action action or Disposed of (D) Securities Indirect
Date Code A Beneficially D Beneficial
(Month/ or Owned at or Ownership
Day/Year) Code V Amount D Price End of Month I
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 03/18/03 M 161,000 A $5.8750 D Direct
Common Stock 03/18/03 S 161,000 D $22.0000 D Direct
Common Stock 03/18/03 M 39,000 A $5.8750 D Direct
Common Stock 03/18/03 S 39,000 D $22.0000 71,261 D Direct
Table II (PART 1) Derivative Securities Acquired, Disposed of, or Beneficially Owned (Columns 1 through 6)
------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative 2)Conversion 3)Trans- 4)Trans- 5)Number of Derivative 6)Date Exercisable and
Security or Exercise action action Securities Acquired (A) Expiration Date
Price of Date Code or Disposed of (D)
Derivative
Security Code V A D Exercisable Expiration
------------------------------------------------------------------------------------------------------------------------------------
Non-Qualified Stock Option $5.8750 03/18/03 M 39,000 (1) 12/31/05
(right to buy)
Non-Qualified Stock Option $5.8750 03/18/03 M 161,000 (1) 12/26/07
(right to buy) (2)
Table II (PART 2) Derivative Securities Acquired, Disposed of, or Beneficially Owned (Columns 1,3 and 7 through 11)
------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative 3)Trans- 7)Title and Amount 8)Price 9)Number of 10) 11)Nature of
Security action of Underlying of Deri- Derivative Indirect
Date Securities vative Securities D Beneficial
Amount or Security Beneficially or Ownership
Number of Owned at I
- Title Shares End of Month
------------------------------------------------------------------------------------------------------------------------------------
Non-Qualified Stock Option 03/18/03 Common Stock 39,000 1,875 D Direct
(right to buy)
Non-Qualified Stock Option 03/18/03 Common Stock 161,000 339,000 D Direct
(right to buy) (2)
Explanation of Responses:
(1) 25% of the options vest one year after the grant date, with the remaining 75% vesting monthly thereafter over 36 months
(2) Granted on December 27, 1997
SIGNATURE OF REPORTING PERSON
/S/ Essig, Stuart M.
DATE 03/18/03